MO‐FG‐213‐04: Managing the Relationship
Authors: Wong J. 
Published: June 2015

Academic‐industrial collaborations are playing an increasingly prominent role in medical physics research. Successful partnerships have enabled truly translational, benchtop‐to‐bedside research that has significantly and positively impacted our field. Given the current flat or depleting trends in federal funding, and the increasing emphasis in the medical physics community on demonstrating translatability, efficacy, and safety prior to widespread clinical use, it is anticipated that such partnerships will become ever more important in advancing our field. In the future, it is likely that neither academia alone, nor industry alone, will be able to bring significant innovation to successfully impact patient care in radiotherapy. Such innovation will require partnership and symbiosis through the lifetime of the project.This symposium is aimed at professionals from academia and the industry who are interested in either initiating new collaborations or maintaining and improving existing partnerships. We will hear from four thought leaders from industry and academia on critical aspects of building and maintaining successful academic‐industrial research partnerships. The following topics will be addressed:1. Motivations: The industry perspective [Kevin Brown, Elekta]What goes into the development of a company's R&D roadmapWhat are the motivations and expectations of the industry from academic partnersHow can academics make a successful pitch by identifying projects aligned with a company's roadmapWhy are some relationships successful and some notMilestones and progress reports ‐ Why do we need them2. Motivations: The academic perspective [T. Rock Mackie, Univ. of Madison, WI; Tomotherapy]What are the motivations and expectations of academic partners from the industryWhat are the cultural differences in academia vs industry on sharing information, exchanging ideasPartnership or entrepreneurship? When does each option make sense3. Industrial Grants and Research Contracts – a Primer [Norbert Pelc; Stanford University]What topics are suited to industrial grants vs. academic grantsHow do resources (personnel effort, tuition) get allocated and charged in academiaWhat are reasonable resource and timeline requests for small and big projects; from small and big companies“Fair market value” considerationsSections of a research agreement (IP including software confidential information, publications, data, exclusivity, support)4. Managing the relationship [John Wong, Johns Hopkins University]How to effectively collaborate with each otherHow to adapt to changes in the relationshipHow to renew funding with the industryModerated Panel Discussion [All speakers + moderators]Learning Objectives:

Understand the motivations of each partner
Elements that contribute to a successful partnership
Avoiding pitfalls ‐ Challenges on either side that may derail a project
How to frame a research grant and agreement
How to sustain the collaborative relationship
Amit Sawant: Funding from: NIH. Varian, Elekta and VisionRT; Michelle Svatos: Employee and shareholder: Varian, Board Member, TopasMC; Kevin Brown: Employee, Elekta; T. Rock Mackie: Consultant, Accuray; Norbert Pelc: Research support: Philips Healthcare, GE Healthcare; John Wong: Funding from NIH, Xstrahl and Elekta. Co‐founder and advisor for JPLC Associates, LLC.